9 June 2021
Dewhurst PLC
("Dewhurst" or the "Company")
Appointment of Non-Executive Directors
Dewhurst plc (AIM: DWHT), is pleased to announce the appointment of Susan McErlain and Charles Holroyd to the Board as Non-Executive Directors from 8th June 2021. Both Susan and Charles have been appointed as members of the Audit and Remuneration Committees of the Board of the Company.
Susan holds a BSc in Banking & International Finance from City University Business School (CASS) and has over 30 years' experience in business and corporate communications. She co-founded financial PR company Square Mile Communications and ran the business until its sale in 2000. Susan then became Chair of Weber Shandwick's financial services division until 2007, after which she continued to provide senior advisory services to several listed engineering companies. In 2014 she became Director of Corporate Affairs for Ultra Electronics Holdings plc until 2019, with responsibilities for investor and stakeholder communications, M&A, and government affairs. Susan is currently a Non-Executive Director of AIM-listed Trackwise Designs plc, a manufacturer of specialist products using printed circuit technology, where she chairs the Remuneration Committee and is a member of the Audit Committee.
Charles holds a BSc in Electrical and Electronics Engineering from Bristol University and an MBA from INSEAD. He is a Chartered Engineer and a Fellow of the Institution of Engineering and Technology and has held senior management positions within a number of publicly quoted companies including Oxford Instruments plc, which he joined in 1999 and where he served on the board from 2005 until 2013 and was responsible for group business development including M&A activities.
Since June 2018 Charles has held the position of Senior Independent Director at Judges Scientific plc, an AIM-listed company specialising in the design and production of scientific instruments, where he is Chairman of the Remuneration Committee and a member of the Audit Committee. Charles is also Non-Executive Chairman of IBEX Innovations Ltd, a developer of innovative medical X-ray imaging software since October 2018.
Additional Information in respect of the AIM Rules
The following information regarding the appointment of Susan Jacqueline McErlain (previous name Susan Jacqueline Ellis (née Richards)), aged 58, is disclosed under Schedule 2(g) of the AIM Rules for Companies:
| Current Directorships | Previous Directorships (within the last five years) |
| Susan Ellis Consultancy Ltd | Corvid Holdings Ltd |
| Trackwise Designs plc | Corvid Protect Holdings Limited |
| | Paygate Payment Solutions Limited |
As at the date of this announcement, Susan McErlain does not hold any ordinary shares in the Company.
The following information regarding the appointment of Charles John Arthur Holroyd, aged 65, is disclosed under Schedule 2(g) of the AIM Rules for Companies:
| Current Directorships | Previous Directorships (within the last five years) |
| IBEX Innovation Ltd | Phase Focus Ltd |
| Judges Scientific plc | Molecular Warehouse Ltd |
| | Oxford Instruments Nanotechnology Tools Limited |
| | Oxford Instruments Industrial Products Limited |
| | Oxford Instruments Overseas Holdings Limited |
| | Oxford Instruments Technology (Shanghai) Company Limited |
| | Oxford Instruments SAS |
| | Oxford Instruments (Shanghai) Company Limited |
| | Oxford Instruments Nordiska AB |
| | Oxford Instruments India Private Limited |
| | Oxford Instruments Private Limited |
| | Scienta Scientific AB |
As at the date of this announcement, Charles Holroyd does not hold any ordinary shares in the Company.
Save as set out above there are no further disclosures pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Susan McErlain and Charles Holroyd.
Contacts:
|
Person responsible:
The person responsible for arranging the release of this announcement on behalf of Dewhurst plc is Jared Sinclair.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.